Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Case report

Malignant fibrous histiocytoma of the distal femur after an arthroscopic anterior cruciate ligament reconstruction: A case report and a review of the literature

Authors: Turgay Efe, Thomas J Heyse, Markus D Schofer, Susanne Fuchs-Winkelmann, Peter Rexin, Jan Schmitt

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Malignant degeneration in association with orthopaedic implants is a known but rare complication. To our knowledge, no case of osseous malignant fibrous histiocytoma after anterior cruciate ligament reconstruction is reported in the literature.

Case presentation

We report a 29-year-old male Turkish patient who presented with severe pain in the operated knee joint 40 months after arthroscopic anterior cruciate ligament reconstruction. X-ray and MR imaging showed a large destructive tumor in the medial femoral condyle. Biopsy determined a malignant fibrous histiocytoma. After neoadjuvant chemotherapy, wide tumor resection and distal femur reconstruction with a silver-coated non-cemented tumor knee joint prosthesis was performed. Adjuvant chemotherapy was continued according to the EURAMOS 1 protocol.

Conclusions

Though secondary malignant degeneration after orthopaedic implants or prostheses is not very likely, the attending physician should take this into consideration, especially if symptoms worsen severely over a short period of time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Majewski M, Susanne H, Klaus S: Epidemiology of athletic knee injuries: A 10-year study. Knee. 2006, 13 (3): 184-188. 10.1016/j.knee.2006.01.005.CrossRefPubMed Majewski M, Susanne H, Klaus S: Epidemiology of athletic knee injuries: A 10-year study. Knee. 2006, 13 (3): 184-188. 10.1016/j.knee.2006.01.005.CrossRefPubMed
2.
go back to reference Weiler A, Scheffler S, Hoher J: Transplant selection for primary replacement of the anterior cruciate ligament. Orthopade. 2002, 31 (8): 731-740. 10.1007/s00132-002-0331-z.CrossRefPubMed Weiler A, Scheffler S, Hoher J: Transplant selection for primary replacement of the anterior cruciate ligament. Orthopade. 2002, 31 (8): 731-740. 10.1007/s00132-002-0331-z.CrossRefPubMed
3.
go back to reference O'Brien JE, Stout AP: Malignant Fibrous Xanthomas. Cancer. 1964, 17: 1445-1455. 10.1002/1097-0142(196411)17:11<1445::AID-CNCR2820171112>3.0.CO;2-G.CrossRefPubMed O'Brien JE, Stout AP: Malignant Fibrous Xanthomas. Cancer. 1964, 17: 1445-1455. 10.1002/1097-0142(196411)17:11<1445::AID-CNCR2820171112>3.0.CO;2-G.CrossRefPubMed
4.
go back to reference Huvos AG, Heilweil M, Bretsky SS: The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am J Surg Pathol. 1985, 9 (12): 853-871. 10.1097/00000478-198512000-00002.CrossRefPubMed Huvos AG, Heilweil M, Bretsky SS: The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am J Surg Pathol. 1985, 9 (12): 853-871. 10.1097/00000478-198512000-00002.CrossRefPubMed
5.
go back to reference McCarthy EF, Matsuno T, Dorfman HD: Malignant fibrous histiocytoma of bone: a study of 35 cases. Hum Pathol. 1979, 10 (1): 57-70. 10.1016/S0046-8177(79)80072-6.CrossRefPubMed McCarthy EF, Matsuno T, Dorfman HD: Malignant fibrous histiocytoma of bone: a study of 35 cases. Hum Pathol. 1979, 10 (1): 57-70. 10.1016/S0046-8177(79)80072-6.CrossRefPubMed
6.
go back to reference Olmedo DG, Michanie E, Oivi L, Santini-Araujo E, Cabrini RL: Malignant fibrous histiocytoma associated with coxofemoral arthrodesis. Tumori. 2007, 93 (5): 504-507.PubMed Olmedo DG, Michanie E, Oivi L, Santini-Araujo E, Cabrini RL: Malignant fibrous histiocytoma associated with coxofemoral arthrodesis. Tumori. 2007, 93 (5): 504-507.PubMed
7.
go back to reference Aboulafia AJ, Littelton K, Shmookler B, Malawer MM: Malignant fibrous histiocytoma at the site of hip replacement in association with chronic infection. Orthop Rev. 1994, 23 (5): 427-432.PubMed Aboulafia AJ, Littelton K, Shmookler B, Malawer MM: Malignant fibrous histiocytoma at the site of hip replacement in association with chronic infection. Orthop Rev. 1994, 23 (5): 427-432.PubMed
8.
go back to reference Domson GF, Shahlaee A, Reith JD, Bush CH, Gibbs CP: Infarct-associated bone sarcomas. Clin Orthop Relat Res. 2009, 467 (7): 1820-1825. 10.1007/s11999-009-0744-7.CrossRefPubMedPubMedCentral Domson GF, Shahlaee A, Reith JD, Bush CH, Gibbs CP: Infarct-associated bone sarcomas. Clin Orthop Relat Res. 2009, 467 (7): 1820-1825. 10.1007/s11999-009-0744-7.CrossRefPubMedPubMedCentral
9.
go back to reference Shaheen M, Deheshi BM, Riad S, Werier J, Holt GE, Ferguson PC, Wunder JS: Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006, 450: 76-81. 10.1097/01.blo.0000229315.58878.c1.CrossRefPubMed Shaheen M, Deheshi BM, Riad S, Werier J, Holt GE, Ferguson PC, Wunder JS: Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006, 450: 76-81. 10.1097/01.blo.0000229315.58878.c1.CrossRefPubMed
10.
go back to reference Ugurlu K, Turgut G, Kabukcuoglu F, Ozcan H, Sanus Z, Bas L: Malignant fibrous histiocytoma developing in a burn scar. Burns. 1999, 25 (8): 764-767. 10.1016/S0305-4179(99)00085-6.CrossRefPubMed Ugurlu K, Turgut G, Kabukcuoglu F, Ozcan H, Sanus Z, Bas L: Malignant fibrous histiocytoma developing in a burn scar. Burns. 1999, 25 (8): 764-767. 10.1016/S0305-4179(99)00085-6.CrossRefPubMed
11.
go back to reference Tomita F, Yasuda K, Mikami S, Sakai T, Yamazaki S, Tohyama H: Comparisons of intraosseous graft healing between the doubled flexor tendon graft and the bone-patellar tendon-bone graft in anterior cruciate ligament reconstruction. Arthroscopy. 2001, 17 (5): 461-476. 10.1053/jars.2001.24059.CrossRefPubMed Tomita F, Yasuda K, Mikami S, Sakai T, Yamazaki S, Tohyama H: Comparisons of intraosseous graft healing between the doubled flexor tendon graft and the bone-patellar tendon-bone graft in anterior cruciate ligament reconstruction. Arthroscopy. 2001, 17 (5): 461-476. 10.1053/jars.2001.24059.CrossRefPubMed
12.
go back to reference Salzer-Kuntschik M, Brand G, Delling G: Determination of the degree of morphological regression following chemotherapy in malignant bone tumors. Pathologe. 1983, 4 (3): 135-141.PubMed Salzer-Kuntschik M, Brand G, Delling G: Determination of the degree of morphological regression following chemotherapy in malignant bone tumors. Pathologe. 1983, 4 (3): 135-141.PubMed
13.
go back to reference Feldman F, Norman D: Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology. 1972, 104 (3): 497-508.CrossRefPubMed Feldman F, Norman D: Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology. 1972, 104 (3): 497-508.CrossRefPubMed
14.
go back to reference Sirveaux F, Hummer N, Roche O, Rios M, Vignaud JM, Mole D: Pleomorphic malignant fibrous histiocytoma at the site of an arthroscopic reconstruction of the anterior cruciate ligament. A case report. J Bone Joint Surg Am. 2005, 87 (2): 404-409. 10.2106/JBJS.C.01207.CrossRefPubMed Sirveaux F, Hummer N, Roche O, Rios M, Vignaud JM, Mole D: Pleomorphic malignant fibrous histiocytoma at the site of an arthroscopic reconstruction of the anterior cruciate ligament. A case report. J Bone Joint Surg Am. 2005, 87 (2): 404-409. 10.2106/JBJS.C.01207.CrossRefPubMed
15.
go back to reference Caron JJ, Pambuccian SE, Steen JT, Cheng EY: Leiomyosarcoma of the distal femur after anterior cruciate ligament reconstruction. Clin Orthop Relat Res. 2004, 214-217. 10.1097/00003086-200402000-00035. 419 Caron JJ, Pambuccian SE, Steen JT, Cheng EY: Leiomyosarcoma of the distal femur after anterior cruciate ligament reconstruction. Clin Orthop Relat Res. 2004, 214-217. 10.1097/00003086-200402000-00035. 419
16.
go back to reference Bader H, Spohner F, Gerlitzky W, Meyer D: Malignant fibrous histiocytoma after supracondylar femoral fracture (author's transl). Dtsch Med Wochenschr. 1981, 106 (11): 336-339. 10.1055/s-2008-1070314.CrossRefPubMed Bader H, Spohner F, Gerlitzky W, Meyer D: Malignant fibrous histiocytoma after supracondylar femoral fracture (author's transl). Dtsch Med Wochenschr. 1981, 106 (11): 336-339. 10.1055/s-2008-1070314.CrossRefPubMed
17.
go back to reference Joss R, Ganz R, Ryssel HJ, Remagen W, Brunner K: Posttraumatic soft tissue sarcoma: a case study of a malignant fibrous histiocytoma of the elbow joint which appeared six and a half years after a severe injury. Schweiz Med Wochenschr. 1980, 110 (52): 2021-2024.PubMed Joss R, Ganz R, Ryssel HJ, Remagen W, Brunner K: Posttraumatic soft tissue sarcoma: a case study of a malignant fibrous histiocytoma of the elbow joint which appeared six and a half years after a severe injury. Schweiz Med Wochenschr. 1980, 110 (52): 2021-2024.PubMed
18.
go back to reference Bacci G, Avella M, Picci P, Capanna R, Fontana M, Dallari D, Campanacci M: The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy. Chemioterapia. 1988, 7 (6): 406-413.PubMed Bacci G, Avella M, Picci P, Capanna R, Fontana M, Dallari D, Campanacci M: The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy. Chemioterapia. 1988, 7 (6): 406-413.PubMed
Metadata
Title
Malignant fibrous histiocytoma of the distal femur after an arthroscopic anterior cruciate ligament reconstruction: A case report and a review of the literature
Authors
Turgay Efe
Thomas J Heyse
Markus D Schofer
Susanne Fuchs-Winkelmann
Peter Rexin
Jan Schmitt
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-264

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine